Key factors for successful generation of proteinfragment structures: Requirement on protein, crystals, and technology

Methods in Enzymology

Volumn 493, Issue , 2011, Pages 61-89

  Bttcher, Jark ^a   Jestel, Anja ^a   Kiefersauer, Reiner ^a   Krapp, Stephan ^a   Nagel, Susanna ^a   Steinbacher, Stefan ^a   Steuber, Holger ^a  

^a PROTEROS BIOSTRUCTURES GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PEPTIDE FRAGMENT; POLYMER; PROTEIN;

ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; LIGAND BINDING; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PH; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENGINEERING; PROTEIN PURIFICATION; PROTEIN STRUCTURE;

EID: 79952370896     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381274-2.00003-0     Document Type: Chapter

References (99)

1. H.S. Andersen, L.F. Iversen, C.B. Jeppesen, S. Branner, K. Norris, H.B. Rasmussen, K.B. Møller, and N.P. Møller 2-(oxalylamino)-benzoic acid is a gneral, competitive inhibitor of protein-tyrosine phophatases J. Biol. Chem. 275 2000 7101 7108 (Pubitemid 30146258)
2. O.A. Andersen, D.L. Schnfeld, I. Toogood-Johnson, B. Felicetti, C. Albrecht, T. Fryatt, M. Whittaker, D. Hallett, and J. Barker Cross-linking of protein crystals as an aid in the generation of binary protein-ligand crystal complexes, exemplified by the human PDE10a-papaverine structure Acta Crystallogr. D 65 2009 872 874
3. M. Anderson, D.M. Andrews, A.J. Barker, C.A. Brassington, J. Breed, K.F. Byth, J.D. Culshaw, M.R. Finlay, E. Fisher, H.H. McMiken, C.P. Green, and D.W. Heaton Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors Bioorg. Med. Chem. Lett. 18 2008 5487 5492
4. S.S. Antonysamy, B. Aubol, J. Blaney, M.F. Browner, A.M. Giannetti, S.F. Harris, N. Hbert, J. Hendle, S. Hopkins, E. Jefferson, C. Kissinger, and V. Leveque Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors Bioorg. Med. Chem. Lett. 18 2008 2990 2995 (Pubitemid 351608863)
5. S.S. Antonysamy, G. Hirst, P. Sprengler, F. Stappenbeck, R. Steensma, M. Wilson, and M. Wong Fragment-based discovery of JAK-2 inhibitors Bioorg. Med. Chem. Lett. 19 2009 279 282
6. M.R. Arkin, M. Randal, W.L. DeLano, J. Hyde, T.N. Luong, J.D. Oslob, D.R. Raphael, L. Taylor, J. Wang, R.S. McDowell, J.A. Wells, and A.C. Braisted Binding of small molecules to an adaptive protein-protein interface PNAS 100 2003 1603 1608 (Pubitemid 36254494)
7. A.M. Aronov, C. Baker, G.W. Bernis, J. Cao, G. Chen, P.J. Ford, U.A. Germann, J. Green, M.R. Hale, M. Jacobs, J.W. Janetka, and F. Maltais Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors J. Med. Chem. 50 2007 1280 1287 (Pubitemid 46496327)
8. P.A. Bartlett, N. Yusuff, A.C. Rico, and M.K. Lindvall Antihydrophobic solvent effects: An experimental probe for the hydrophobic contribution to enzyme-inhibitor binding J. Am. Chem. Soc. 124 2002 3853 3857 (Pubitemid 34310899)
9. N. Benson, H.F. Boyd, J.R. Everett, J. Fries, P. Gribbon, N. Haque, K. Henco, T. Jessen, W.H. Martin, T.J. Mathewson, R.E. Sharp, and R.W. Spencer NanoStore: A concept for logistical improvements of compound handling in high-throughput screening J. Biomol. Screen. 10 2005 573 580 (Pubitemid 41306655)
10. J. Bosch, M.A. Robien, C. Mehlin, E. Boni, A. Riechers, F.S. Buckner, W.C. Van Voorhis, P.J. Myler, E.A. Worthey, G. DeTitta, J.R. Luft, and A. Lauricella Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase J. Med. Chem. 49 2006 5939 5946 (Pubitemid 44484940)
11. A.C. Braisted, J.D. Oslob, W.L. Delano, J. Hyde, R.S. McDowell, N. Waal, C. Yu, M.R. Arkin, and B.C. Raimundo Discovery of a potent small molecule IL-2 inhibitor through fragment assembly J. Am. Chem. Soc. 125 2003 3714 3715 (Pubitemid 36512355)
12. R. Brenk, S.W. Vetter, S.E. Boyce, D.B. Goodin, and B.K. Shoichet Probing molecular docking in a charged model binding site J. Mol. Biol. 357 2006 1449 1470
13. P.A. Brough, X. Barril, J. Borgognoni, P. Chene, N.G. Davies, B. Davis, M.J. Drysdale, B. Dymock, S.A. Eccles, C. Garcia-Echeverria, C. Fromont, and A. Hayes Combining hit identification strategies: Fragment-based and in silico approaches to orally active 2-aminothieno[2, 3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone J. Med. Chem. 52 2009 4794 4809
14. G.L. Card, B.P. England, Y. Suzuki, D. Fong, B. Powell, B. Lee, C. Luu, M. Tabrizizad, S. Gillette, P.N. Ibrahim, D.R. Artis, and G. Bollag Structural basis for the activity of drugs that inhibit phosphodiesterases Structure 12 2004 2233 2247 (Pubitemid 39593200)
15. R.A.E. Carr, M. Congreve, C.W. Murray, and D.C. Rees Fragment-based lead discovery: Leads by design Drug Discov. Today 10 2005 987 992 (Pubitemid 40967047)
16. J.H. Carra, C.A. McHugh, S. Mulligan, L.M. Machiesky, A.S. Soares, and C.B. Millard Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site BMC Struct. Biol. 7 2007 72
17. Y. Chen, and B.K. Shoichet Molecular docking and ligand specificity in fragment-based inhibitor discovery Nat. Chem. Biol. 5 2009 358 364
18. C.-W. Chung The use of biophysical methods increases success in obtaining liganded crystal structures Acta Crystallogr. D 63 2007 62 71 (Pubitemid 46141481)
19. S. Chung, J.B. Parker, M. Bianchet, L.M. Amzel, and J.T. Stivers Impact of linker strain and flexibility in the design of a fragment-based inhibitor Nat. Chem. Biol. 5 2009 407 413
20. M. Congreve, R. Carr, C. Murray, and H. Jhoti A 'Rule of Three' for fragment-based lead discovery? Drug Discov.Today 8 2003 876 877 (Pubitemid 37194496)
21. M. Congreve, G. Chessari, D. Tisi, and A.J. Woodhead Recent developments in fragment-based drug discovery J. Med. Chem. 51 2008 3661 3680 (Pubitemid 351956496)
22. A.G. Coyne, D.E. Scott, and C. Abell Drugging challenging targets using fragment-based approaches Curr. Opin. Chem. Biol. 14 2010 299 307
23. D.E. Danley Crystallization to obtain protein-ligand complexes for structure-aided drug design Acta Crystallogr. D 62 2006 569 575 (Pubitemid 43806633)
24. T.G. Davies, M.L. Verdonk, B. Graham, S. Saalau-Bethell, C.C.F. Hamlett, T. McHardy, I. Collins, M.D. Garrett, P. Workman, S.J. Woodhead, H. Jhoti, and D. Barford A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera J. Mol. Biol. 367 2007 882 894 (Pubitemid 46335912)
25. D.R. Davies, B. Mamat, O.T. Magnusson, J. Christensen, M.H. Haraldsson, R. Mishra, B. Pease, E. Hansen, J. Singh, D. Zembower, H. Kim, and A.S. Kiselyov Discovery of Leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography J. Med. Chem. 52 2009 4694 4715
26. A.M. Davis, S.J. Teague, and G.J. Kleywegt Application and limitations of X-ray crystallographic data in structure-based ligand and drug design Angew. Chem. Int. Ed. 42 2003 2718 2736 (Pubitemid 36813974)
27. A.M. Davis, S.A. St-Gallay, and G.J. Kleywegt Limitations and lessons in the use of X-ray structural information in drug design Drug Discov. Today 13 2008 831 841
28. D.A. Doyle, C.J. Morais, R.A. Pfuetzner, A. Kuo, J.M. Gulbis, S.L. Cohen, B.T. Chait, and R. MacKinnon The structure of the potassium channel: Molecular basis of K+ conduction and selectivity Science 280 1998 69 77 (Pubitemid 28169082)
29. M. Engel, T. Hoffmann, S. Manhart, U. Heiser, S. Chambre, R. Huber, H.U. Demuth, and W. Bode Rigidity and flexibility of dipeptidyl peptidase IV: Crystal structures of and docking experiments with DPIV J. Mol. Biol. 355 2006 768 783 (Pubitemid 41817635)
30. R. Engh, A. Girod, V. Kinzel, R. Huber, and D. Bossemeyer Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity J. Biol. Chem. 271 1996 26157 26164 (Pubitemid 26347460)
31. L. Englert, A. Biela, M. Zayed, A. Heine, D. Hangauer, D. Hangauer, and G. Klebe Displacement of disordered water molecules from hydrophobic pocket creates enthalpic signature: binding of phosphonamidate to the S(1)'-pocket of thermolysin Biochim. Biophys. Acta 1800 2010 1192 1202
32. A.C. English, C.R. Groom, and R.E. Hubbard Experimental and computational mapping of the binding surface of a crystalline protein Protein Eng. 14 2001 47 59 (Pubitemid 32318937)
33. D.A. Erlanson Fragment-based lead discovery: A chemical update Curr. Opin. Biotechnol. 17 2006 643 652 (Pubitemid 44791912)
34. D.A. Erlanson, and S.K. Hansen Making drugs on proteins: Site-directed ligand discovery for fragment-based lead assembly Curr. Opin. Chem. Biol. 8 2004 399 406 (Pubitemid 38993733)
35. R. Fedorov, D.K. Ghosh, and I. Schlichting Crystal structures of cyanide complexes of P450cam and the oxgenase domain of inducile nitric oxide synthase-structural models of the short-lived oxygen complexes Arch. Biochem. Biophys. 409 2003 25 31 (Pubitemid 36042898)
36. M. Frederickson, O. Callaghan, G. Chessari, M. Congreve, S.R. Cowan, J.E. Matthews, R. McMenamin, D.M. Smith, M. Vinkovi, and N.G. Wallis Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator J. Med. Chem. 51 2008 183 186
37. C. Gerlach, M. Smolinski, H. Steuber, C.A. Sotriffer, A. Heine, D.G. Hangauer, and G. Klebe Thermodynamic inhibition profile of a cyclopentyl and a cyclohexyl derivative towards thrombin: The same but for different reasons Angew. Chem. Int. Ed. 46 2007 8511 8514 (Pubitemid 350114974)
38. S. Geschwindner, L.-L. Olsson, J.S. Albert, J. Deinum, P.D. Edwards, T. de Beer, and R.H.A. Folmer Discovery of a Novel Warhead against beta-secretase through fragment-based lead generation J. Med. Chem. 50 2007 5903 5911
39. D.K. Ghosh, M.B. Rashid, B. Crane, V. Taskar, M. Mast, M.A. Misukonis, J.B. Weinberg, and N.T. Eissa Characterization of key residues in the subdomain encoded by exons 8 and 9 of human inducible nitric oxide synthase: A critical role for Asp-280 in substrate binding and subunit interactions PNAS 98 2001 10392 10397 (Pubitemid 32803030)
40. A.L. Gill, M. Frederickson, A. Cleasby, S.J. Woodhead, M.G. Carr, A.J. Woodhead, M.T. Walker, M.S. Congreve, L.A. Devine, D. Tisi, M. O'Reilly, and L.C. Seavers Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation J. Med. Chem. 48 2005 414 426 (Pubitemid 40139784)
41. R. Godemann, J. Madden, J. Krmer, M. Smith, U. Fritz, T. Hesterkamp, J. Barker, S. Hppner, D. Hallett, A. Cesura, A. Ebneth, and J. Kemps Fragment-based discovery of BACE inhibitors using functional assays Biochemistry 48 2009 10743 10751
42. P.J. Hajduk, and J. Greer A decade of fragment-based drug design: Strategic advances and lessons learned Nat. Rev. Drug Discov. 6 2007 211 219 (Pubitemid 46344625)
43. M.M. Hann, A.R. Leach, and G. Harper Molecular complexity and its impact on the probability of finding leads for drug discovery J. Chem. Inf. Comput. Sci. 41 2001 856 864
44. S.B. Hansen, G. Sulzenbacher, T. Huxford, P. Marchot, P. Taylor, and Y. Bourne Structure of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distictive binding interfaces and confirmations EMBO J. 24 2005 3635 3646 (Pubitemid 41509370)
45. M.J. Hartshorn, C.W. Murray, A. Cleasby, M. Frederickson, I.J. Tickle, and H. Jhoti Fragment-based Lead discovery using X-ray crystallography J. Med. Chem. 48 2005 403 413 (Pubitemid 40139783)
46. A.M. Hassell, G. An, R.K. Bledsoe, J.M. Bynum, H.L. Carter III, S.-J.J. Deng, R.T. Gampe, T.E. Grisard, K.P. Madauss, R.T. Nolte, W.J. Rocque, and L. Wang Crystallization of protein-ligand complexes Acta Crystallogr. D 63 2007 72 79 (Pubitemid 46141482)
47. H. Heaslet, R. Rosenfeld, M. Giffin, Y.C. Lin, K. Tam, B.E. Torbett, J.H. Elder, D.E. McRee, and C.D. Stout Conformational flexibility in the flap domains of ligand-free HIV protease Acta Crystallogr. D 63 2007 866 875 (Pubitemid 47094569)
48. M. Hendlich, A. Bergner, J. Günther, and G. Klebe Relibase: Design and development of a database for comprehensive analysis of protein-ligand interactions J. Mol. Biol. 326 2003 607 620 (Pubitemid 36279352)
49. M. Hohwy, L. Spadola, B. Lundquist, P. Hawtin, J. Dahmn, I. Groth-Clausen, E. Nilsson, S. Persdotter, K. von Wachenfeldt, R.H. Folmer, and K. Edman Novel prostaglandin D synthase inhibitors generated by fragment-based drug design J. Med. Chem. 51 2008 2178 2186 (Pubitemid 351503273)
50. M.A. Holmes, and B.W. Matthews Binding of hydroxamic acid inhibitors to crystalline thermolysin suggests a pentacoordinate zinc intermediate in catalysis Biochemistry 20 1981 6912 6920
51. I.P. Holmes, S. Gaines, S.P. Watson, O. Lorthioir, A. Walker, S.J. Baddeley, S. Herbert, D. Egan, M.A. Convery, O.M. Singh, J.W. Gross, and J.M. Strelow The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors Bioorg. Med. Chem. Lett. 19 2009 5760 5763
52. N. Howard, C. Abell, W. Blakemore, G. Chessari, M. Congreve, S. Howard, H. Jhoti, C.W. Murray, L.C.A. Seavers, and R.L.M. van Montfort Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors J. Med. Chem. 49 2006 1346 1355 (Pubitemid 43271886)
53. S. Howard, V. Berdini, J.A. Boulstridge, M.G. Carr, D.M. Cross, J. Curry, L.A. Devine, T.R. Early, L. Fazal, A.L. Gill, M. Heathcote, and S. Maman Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity J. Med. Chem. 52 2009 379 388
54. A.W. Hung, H.L. Silvestre, S. Wen, A. Ciulli, T.L. Blundell, and C. Abell Application of fragment growing and fragment linking to the discovery of inhibitors of mycobacterium tuberculosis panththenate synthase Angew. Chem. Int. Ed. 48 2009 8452 8456
55. J.R. Huth, C. Park, A.M. Petros, A.R. Kunzer, M.D. Wendt, X. Wang, C.L. Lynch, J.C. Mack, K.M. Swift, R.A. Judge, J. Chen, and P.L. Richardson Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies Chem. Biol. Drug Des. 70 2007 1 12 (Pubitemid 47057425)
56. J. Hyde, A.C. Braisted, M. Randal, and M.R. Arkin Discovery and characterization of cooperative ligand binding in the adaptive region of interleukin-2 Biochemistry 42 2003 6475 6483 (Pubitemid 36665822)
57. L.F. Iversen, H.S. Andersen, S. Branner, S.B. Mortensen, G.H. Peters, K. Norris, O.H. Olsen, C.B. Jeppesen, B.F. Lundt, W. Ripka, K.B. Møller, and N.P. Møller Structure-based design of a low molecular weight, nonphosphorus, nonpeptide, and highly selective inhibitor of protein-tyrosine phosphatase 1B J. Biol. Chem. 275 2000 10300 10307 (Pubitemid 30202088)
58. A. Joachimiak High-throughput crystallography for structural genomics Curr. Opin. Struct. Biol. 19 2009 573 584
59. B.A. Katz, K. Elrod, C. Luong, M.J. Rice, R.L. Mackman, P.A. Sprengeler, J. Spencer, J. Hataye, J. Janc, J. Link, J. Litvak, and R. Rai A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site J. Mol. Biol. 307 2001 1451 1486 (Pubitemid 33027652)
60. R. Kiefersauer, M.E. Than, H. Dobbek, L. Gremer, M. Melero, S. Strobl, J.M. Dias, T. Soulimane, and R. Huber A novel free-mounting system for protein crystal transformation and improvement of diffraction power by accurately controlled humidity change J. Appl. Cryst. 33 2000 1223 1230 (Pubitemid 32120467)
61. A.M. Lawrie, M.E. Noble, P. Tunnah, N.R. Brown, L.N. Johnson, and J.A. Endicott Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2 Nat. Struct. Biol. 4 1997 796 801
62. E.F. Lee, P.E. Czabotar, B.J. Smith, K. Deshayes, K. Zobel, P.M. Colman, and W.D. Fairlie Crystal structure of ABT-737 complexed with Bcl-XL: Implications for selectivity of antagonists of the Bcl-2 family Cell Death Differ. 14 2007 1711 1713 (Pubitemid 47278856)
63. D.D. Leonidas, R. Shapiro, L.I. Irons, N. Russo, and K.R. Acharya Crystal structures of ribonuclease A complexes with 5′-diphosphoadenosine 3′-phosphate and 5′-diphosphoadenosine 2′phosphate at 1.7 A resolution Biochemistry 36 1997 5578 5588 (Pubitemid 27200056)
64. M.S. Malamas, E.S. Manas, R.E. McDevitt, I. Gunawan, Z.B. Xu, M.D. Collini, C.P. Miller, T. Dinh, R.A. Henderson, J.C. Keith Jr., and H.A. Harris Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-b ligands J. Med. Chem. 47 2004 5021 5040 (Pubitemid 39314900)
65. E.S. Manas, R.J. Unwalla, Z.B. Xu, M.S. Malamas, C.P. Miller, H.A. Harris, C. Hsiao, T. Akopian, W.T. Hum, K. Malakian, S. Wolfrom, and A. Bapat Structure-based design of estrogen receptor-beta selective ligands J. Am. Chem. Soc. 126 2004 15106 15119 (Pubitemid 39557270)
66. C. Mattos, C.R. Bellamacina, E. Peisach, A. Pereira, D. Vitkup, G.A. Petsko, and D. Ringe Multiple solvent crystal structures: Probing binding sites, plasticity and hydration J. Mol. Biol. 357 2006 1471 1482
67. F.M. McMillan, J. Archbold, M.J. McLeish, J.M. Caine, K.R. Criscione, G.L. Grunewald, and J.L. Martin Molecular recognition of sub-micromolar inhibitors by the epinephrine-synthesizing enzyme phenylethanolamine N-methyltransferase J. Med. Chem. 47 2004 37 44 (Pubitemid 38040488)
68. A. McPherson Current approaches to macromolecular crystallization Eur. J. Biochem. 189 1990 1 23 (Pubitemid 20140947)
69. I. Mochalkin, J.R. Miller, L. Narasimhan, V. Thanabal, P. Erdman, P.B. Cox, J.V. Prasad, S. Lightle, M.D. Huband, and C.K. Stover Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches ACS Chem. Biol. 4 2009 473 483
70. S.W. Muchmore, M. Sattler, H. Liang, R.P. Meadows, J.E. Harlan, H.S. Yoon, D. Nettesheim, B.S. Chang, C.B. Thompson, S.L. Wong, S.L. Ng, and S.W. Fesik X-ray and NMR structure of human Bcl-XL, an inhibitor of programmed cell death Nature 381 1996 335 341
71. C.W. Murray, and T.L. Blundell Structural biology in fragment-based drug design Curr. Opin. Struct. Biol. 20 2010 1 11
72. C.W. Murray, O. Callaghan, G. Chessari, A. Cleasby, M. Congreve, M. Frederickson, M.J. Hartshorn, R. McMenamin, S. Patel, and N. Wallis Application of fragment screening by X-ray crystallography to beta-secretase J. Med. Chem. 50 2007 1116 1123 (Pubitemid 46496312)
73. R.A. Musah, G.M. Jensen, S.W. Bunte, R.J. Rosenfeld, and D.B. Goodin Artificial protein cavities as specific ligand-binding templates: Characterization of an engineered heterocyclic cation-binding site that preserves the evolved specificity of the parent protein J. Mol. Biol. 315 2002 845 857 (Pubitemid 34729331)
74. S. Patel, L. Vuillard, A. Cleasby, C.W. Murray, and J. Yon Apo and inhibitor complex structures of BACE ([beta]-secretase) J. Mol. Biol. 343 2004 407 416 (Pubitemid 39296874)
75. A.L. Perryman, Q. Zhang, H.H. Soutter, R. Rosenfeld, D.E. McRee, A.J. Olson, J.E. Elder, and C.D. Stout Fragment-based Screen against HIV protease Chem. Biol. Drug Des. 75 2010 257 268
76. A.M. Petros, J. Dinges, D.J. Augeri, S.A. Baumeister, D.A. Betebenner, M.G. Bures, S.W. Elmore, P.J. Hajduk, M.K. Joseph, S.K. Landis, D.G. Nettesheim, and S.H. Rosenberg Discovery of a potent inhibitor of the antiapoptotic protein Bcl-XL from NMR and Parallel synthesis J. Med. Chem. 49 2006 656 663 (Pubitemid 43157495)
77. B. Pillai, K.K. Kannan, and M.V. Hosur 1.9 X-ray study shows closed flap conformation in crystals of tethered HIV-1 PR Proteins 43 2001 57 64 (Pubitemid 32194907)
78. L.M. Podust, J.P. von Kries, A.N. Eddine, Y. Kim, L.V. Yermalitskaya, R. Kuehne, H. Ouellet, T. Warrier, M. Altekster, J.S. Lee, J. Rademann, and H. Oschkinat Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography Antimicrob. Agents Chemother. 5 2007 3915 3923 (Pubitemid 350057789)
79. S.G. Rasmussen, H.J. Choi, D.M. Rosenbaum, T.S. Kobilka, F.S. Thian, P.C. Edwards, M. Burghammer, V.R. Ratnala, R. Sanishvili, R.F. Fischetti, G.F. Schertler, and W.I. Weis Crystal structure of the human beta2 adrenergic G-protein-coupled receptor Nature 450 2007 383 387 (Pubitemid 350126755)
80. D.C. Rees, M. Congreve, C.W. Murray, and R. Carr Fragment-based lead discovery Nat. Rev. Drug Discov. 3 2004 660 672 (Pubitemid 39173507)
81. J. Rosenblatt, H. De Bondet, J. Jancarik, D.O. Morgan, and S.H. Kim Purification and crystallization of human cyclin-dependent kinase 2 J. Mol. Biol. 230 1993 1317 1319 (Pubitemid 23180069)
82. G. Saxty, S.J. Woodhead, V. Berdini, T.G. Davies, M.L. Verdonk, P.G. Wyatt, R.G. Boyle, D. Barford, R. Downham, M.D. Garrett, and R.A. Carr Identification of inhibitors of protein kinase B using fragment-based lead discovery J. Med. Chem. 50 2007 2293 2296 (Pubitemid 46799240)
83. R. Schiffmann, A. Heine, G. Klebe, and C.D. Klein Metal ions as cofactors for the binding of inhibitors to methionine aminopeptidase: A critical view of the relevance of in vitro metalloenzyme assays Angew. Chem. Int. Ed. Engl. 44 2005 3620 3623 (Pubitemid 40831829)
84. A.D. Scott, C. Phillips, A. Alex, M. Flocco, A. Bent, A. Randall, R. O'Brien, L. Damian, and L.H. Jones Thermodynamic optimization in drug discovery: A case study using carbonic anhydrase inhibitors ChemMedChem. 4 2009 1985 1989
85. B.S. Selinski, K. Gupta, C.T. Sharkey, and P.J. Loll Structural analysis of NSAID binding by prostaglandine H2-synthase: Time-dependent and time-independent inhibitors elicit identical enzyme conformations Biochemistry 40 2001 5172 5180 (Pubitemid 32373999)
86. G.M. Sheldrick A short history of SHELX Acta Crystallogr. A 64 2008 112 122
87. K. Sichler, D.W. Banner, A. Drcy, K.P. Hopfner, R. Huber, W. Bode, G.B. Kresse, E. Kopetzki, and H. Brandstetter Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions J. Mol. Biol. 322 2002 591 603
88. H. Steuber, M. Zentgraf, A. Podjarny, A. Heine, and G. Klebe High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group J. Mol. Biol. 356 2006 45 56 (Pubitemid 43069726)
89. M.T. Stubbs, S. Reyda, F. Dullweber, M. Mller, G. Klebe, D. Dorsch, W.W. Mederski, and H. Wurziger pH-Dependent binding modes observed in trypsin crystals: Lessons for structure-based drug design Chembiochem 3 2002 246 249 (Pubitemid 36004503)
90. B.G. Szczepankiewicz, G. Liu, P.J. Hajduk, C. Abad-Zapatero, Z. Pei, Z. Xin, T.H. Lubben, J.M. Trevillyan, M.A. Stashko, S.J. Ballaron, H. Liang, and F. Huang Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy J. Am. Chem. Soc. 125 2003 4087 4096 (Pubitemid 36512302)
91. D.G. Teotico, K. Babaoglu, G.J. Rocklin, R.S. Ferreira, A.M. Giannetti, and B.K. Shoichet Docking for fragment inhibitors of AmpC beta-lactamase PNAS 106 2009 7455 7460
92. C.D. Thanos, M. Randal, and J.A. Wells Potent small-molecule binding to a dynamic hot spot on IL-2 J. Am. Chem. Soc. 125 2003 15280 15281 (Pubitemid 37532159)
93. E. Toyota, K.K. Ng, H. Sekizaki, K. Itoh, K. Tanizawa, and M.N. James X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates J. Mol. Biol. 305 2001 471 479 (Pubitemid 33034614)
94. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, and S. Fisher {Beta}-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
95. C.L.M.J. Verlinde, E. Fan, S. Shibata, Z. Zhang, Z. Sun, W. Deng, J. Ross, J. Kim, L. Xiao, T.L. Arakaki, J. Bosch, and J.M. Caruthers Fragment-based cocktail crystallography by the medical structural genomics of pathogenic protozoa consortium Curr. Top. Med. Chem. 9 2009 1678 1687
96. Z. Wang, P.C. Harkins, R.J. Ulevitch, J. Han, M.H. Cobb, and E.J. Goldsmith The structure of mitogen-activated protein kinase p38 at 2.1-A resolution PNAS 94 1997 2327 2332
97. T.G. Wang, R.A. Mantei, M. Kawai, J.S. Tedrow, D.M. Barnes, J. Wang, Q. Zhang, P. Lou, L.A. Garcia, J. Bouska, M. Yates, and C. Park Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids Bioorg. Med. Chem. Lett. 17 2007 2817 2822 (Pubitemid 46636248)
98. Y.S. Wang, C. Strickland, J.H. Voigt, M.E. Kenedy, B.M. Beyer, M.M. Senior, E.M. Smith, T.L. Nechuta, V.S. Madison, M. Czarniecki, B.A. McKittrick, and A.W. Stamford Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors J. Med. Chem. 53 2010 942 950
99. S.-y. Wu, J. Dornan, G. Kontopidis, P. Taylor, and M.D. Walkinshaw The first direct determination of a ligand binding constant in protein crystals Angew. Chem. Int. Ed. 40 2001 582 586 (Pubitemid 32144470)